3,641 result(s) found
Radian Group (RDN) Up 39.8% in a Year: More Room for Growth?
https://www.zacks.com/stock/news/2194041/radian-group-rdn-up-39-8-in-a-year-more-room-for-growth?cid=CS-ZC-FT-analyst_blog|price_surge_/_plunge-2194041
Dec 06, 2023 - Radian Group (RDN) stock rallies on the back of improved persistency and mortgage insurance portfolio, robust capital position as well as prudent capital deployment.
0
Syros Presents Positive Phase 2 Trial Data Of Tamibarotene Combination: Stock Up In Premarket
https://www.rttnews.com/story.aspx?Id=3409889
Dec 06, 2023 - Syros Pharmaceuticals (SYRS) announced Wednesday positive initial data from its ongoing SELECT-AML-1 Phase 2 trial evaluating tamibarotene, in combination with venetoclax and azacitidine in newly diagnosed, unfit patients with acute myeloid leukemia or AML and RARA gene overexpression.
0
Why Snowflake Stock Rose 29% Last Month
https://www.fool.com/investing/2023/12/05/why-snowflake-stock-rose-29-last-month/?source=iedfolrf0000001
Dec 05, 2023 - Growth hasn't slowed as much as feared, but it might need to pick up the pace to keep satisfying investors.
0
Lawmakers ramp up scrutiny of Shein, call for proof it doesn't use forced labor after retailer files for IPO
https://www.cnbc.com/2023/12/05/shein-ipo-lawmakers-scrutinize-forced-labor.html
Dec 05, 2023 - Lawmakers are ramping up their scrutiny of Shein and calling for proof it doesn't use forced labor after the retailer confidentially filed to go public.
0
Jefferies (JEF) Strengthens Canada Presence, Sets Up IB Unit
https://www.zacks.com/stock/news/2193819/jefferies-jef-strengthens-canada-presence-sets-up-ib-unit?cid=CS-ZC-FT-analyst_blog|company_news_-_finance_sector-2193819
Dec 05, 2023 - Jefferies (JEF) strengthens its footprint in Canada with the new investment banking unit.
0
Alterity (ATHE) Up on Preclinical Parkinson's Treatment Data
https://www.zacks.com/stock/news/2193796/alterity-athe-up-on-preclinical-parkinson-s-treatment-data?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2193796
Dec 05, 2023 - Data from a preclinical study shows that treatment with Alterity's (ATHE) lead candidate improved motor performance and general function in monkeys with experimentally-induced Parkinson's disease.
0
GMS Gears Up to Report Q2 Earnings: Will It Disappoint?
https://www.zacks.com/stock/news/2193793/gms-gears-up-to-report-q2-earnings-will-it-disappoint?cid=CS-ZC-FT-analyst_blog|earnings_preview-2193793
Dec 05, 2023 - Low steel prices and high costs are likely to be reflected in GMS' fiscal Q2 performance.
0
Culp's (CULP) Q2 Earnings & Revenues Beat Estimates, Stock Up
https://www.zacks.com/stock/news/2193792/culp-s-culp-q2-earnings-revenues-beat-estimates-stock-up?cid=CS-ZC-FT-analyst_blog|earnings_article-2193792
Dec 05, 2023 - Despite the ongoing demand softness, Culp's (CULP) fiscal second-quarter 2024 results benefit from strong Mattress Fabrics segment contribution and improved pricing and margin.
0
Hanover Insurance (THG) Ups Dividend to Share More Profit
https://www.zacks.com/stock/news/2193730/hanover-insurance-thg-ups-dividend-to-share-more-profit?cid=CS-ZC-FT-analyst_blog|company_news_-_finance_sector-2193730
Dec 05, 2023 - Hanover Insurance's (THG) recent dividend hike reflects its intention to enhance shareholders' value, supported by a strong financial position.
0
Atlas Copco AB (ATLKY) Is Up 2.95% in One Week: What You Should Know
https://www.zacks.com/stock/news/2193732/atlas-copco-ab-atlky-is-up-2-95-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2193732
Dec 05, 2023 - Does Atlas Copco AB (ATLKY) have what it takes to be a top stock pick for momentum investors? Let's find out.
0